2007 Publications

Battista N, Bari M, Tarditi A, Mariotti C, Bachoud-Lévi A-C, Zuccato C, Finazzi-Agro A, Genitrini S, Peschanski M, Di Donato S, Cattaneo E, Maccarrone M. Severe deficiency of the fatty acid amide hydrolase (FAAH) activity segregates with the Huntington’s disease mutation in peripheral lymphocytes. Neurobiol Dis, 2007, Jul;27(1):108-16

Camos, V., Sieroff, E., Mariller, A., & Couette, M.. Subitizing is attention demanding: A hemineglect case study. International Journal of Psychology Research, 2007, 1(1), 11-21

Créange A, Serre I, Levasseur M, Audry D, Nineb A, Boërio D, Moreau T, Maison P; Réseau SINDEFI-SEP. Walking capacities in multiple sclerosis measured by global positioning system podometer. Mult Scler 2007, Mar;13(2):22

De Diego-Balaguer R, Toro JM, Rodriguez-Fornells A, Bachoud-Lévi A-C. Different neurophysiological mechanisms underlying word and rule extraction from speech. PLoS ONE, 2007, Nov 14; 2(11):e117

Giraud AL, Neumann K, Bachoud-Lévi A-C, von Gudenberg AW, Euler HA, Lanfermann H, Preibisch C. Severity of dysfluency correlates with basal ganglia activity in persistent developmental stuttering. Brain Lang, 2007, May 23; [Epub ahead of print]

Jacquemot C, Dupoux E, Bachoud-Lévi A-C. Breaking the mirror: asymmetrical disconnection between the phonological input and output levels. Cognitive Neuropsychology, 2007,24(1):3-22

Krystkowiak P, Gaura V, Labalette M, Rialland A, Remy P, Peschanski M, Bachoud-Lévi A-C. Alloimmunisation to Donor Antigens and Immune Rejection Following Foetal Neural Grafts to the Brain in Patients with Huntington’s Disease. PLoS ONE. 2007 Jan 24;2:e166.

Paris A, Nogueira da Gama Chaves D, Cornu C, Maison P, Salvat-Mélis M, Ribuot C, Brandt C, Bosson JL, Hommel M, Cracowski JL. Improvement of the comprehension of written information given to healthy volunteers in biomedical research: a single-blind randomized controlled study. Fundam Clin Pharmacol, 2007, Apr 21(2): 207-14

Kreisler A, Mastain B, Tison F, Fénelon G, Destée A [Multi-infarct disorder presenting as corticobasal degeneration (DCB): vascular pseudo-corticobasal degeneration?] Rev Neurol (Paris), 2007, 163: 1191-1199. [in French]

Varani K*, Bachoud-Lévi A-C*, Mariotti C*, Tarditi A*, Abbracchio MP, Gasperi V, Borea PA, Dolbeau G, Gellera C, Solari A, Rosser A, Naji J, Handley O, Maccarrone M, Peschanski M, Didonato S, Cattaneo E.. Biological abnormalities of peripheral A(2A) receptors in a large representation of polyglutamine disorders and Huntington’s disease stages. Neurobiol Dis, 2007, Jul; 27(1): 36-43. Epub 2007 Apr 5. * Co-premiers auteurs

Villafane G, Cesaro P, Rialland A, Baloul S, Azimi S, Bourdet C, Le Houezec J, Macquin-Mavier I, Maison P. Chronic high dose transdermal nicotine in Parkinson’s disease: an open tria Eur J Neurol. 2007 Dec; 14(12): 1313-6. Epub, 2007, Oct 17.PMID: 17941858

Witjes-Ane MN, Mertens B, van Vugt JP, Bachoud-Lévi A-C, van Ommen GJ, Roos RA. Longitudinal evaluation of “presymptomatic” carriers of Huntington’s disease. J Neuropsychiatry Clin Neurosci, 2007,Summer; 19(3): 310-7.